Home › Companies › VERTEX PHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and VERTEX PHARMACEUTICALS INC.’s Form 8-K, filed May 15, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 15, 2024: 15 items on VERTEX PHARMACEUTICALS INC.’s Form 8-K, filed May 15, 2024: 3 approved · 11 passed (calculated) · 1 not approved.
High dissent: 1 shareholder proposal (72.3% support).
Significant dissent: 1 shareholder proposal (28.8% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore VERTEX PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are VERTEX PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Sangeeta Bhatia | 221,206,626 | 808,512 | 182,981 | -- | 11,540,149 | 99.6% | Passed (calculated) | — |
| Elect Director: Lloyd Carney | 213,533,037 | 8,478,558 | 186,524 | -- | 11,540,149 | 96% | Passed (calculated) | — |
| Elect Director: Alan Garber | 220,695,587 | 1,315,689 | 186,843 | -- | 11,540,149 | 99.4% | Passed (calculated) | — |
| Elect Director: Reshma Kewalramani | 221,328,875 | 695,546 | 173,698 | -- | 11,540,149 | 99.7% | Passed (calculated) | — |
| Elect Director: Michel Lagarde | 221,776,280 | 234,937 | 186,902 | -- | 11,540,149 | 99.9% | Passed (calculated) | — |
| Elect Director: Jeffrey Leiden | 217,823,643 | 4,195,522 | 178,954 | -- | 11,540,149 | 98% | Passed (calculated) | — |
| Elect Director: Diana McKenzie | 218,220,365 | 3,797,695 | 180,059 | -- | 11,540,149 | 98% | Passed (calculated) | — |
| Elect Director: Bruce Sachs | 207,616,033 | 14,397,759 | 184,327 | -- | 11,540,149 | 94% | Passed (calculated) | — |
| Elect Director: Jennifer Schneider | 221,774,054 | 240,910 | 183,155 | -- | 11,540,149 | 99.9% | Passed (calculated) | — |
| Elect Director: Nancy Thornberry | 221,772,658 | 241,378 | 184,083 | -- | 11,540,149 | 99.9% | Passed (calculated) | — |
| Elect Director: Suketu Upadhyay | 221,237,300 | 770,815 | 190,004 | -- | 11,540,149 | 99.7% | Passed (calculated) | — |
| Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 | 229,460,523 | 3,987,619 | 290,126 | -- | 0 | 98% | Approved | — |
| Based upon the following votes, the shareholders approved, on an advisory basis, the 2023 compensation program for the Company's named executive officers | 202,098,575 | 19,223,784 | 875,760 | -- | 11,540,149 | 91% | Approved | — |
| Based upon the following votes, the shareholders approved a shareholder proposal regarding a special shareholder meeting improvement | 160,438,357 | 61,494,550 | 265,212 | -- | 11,540,149 | 72% | Approved | — |
| Based upon the following votes, the shareholders did not approve a shareholder proposal regarding a report on racial and gender pay gaps | 63,865,687 | 157,637,997 | 694,435 | -- | 11,540,149 | 29% | Not approved | — |
Source: VERTEX PHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 15, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
1,145 asset managers disclosed a vote on at least one VERTEX PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Sangeeta Bhatia
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Sangeeta Bhatia”): 221,206,626 for, 808,512 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,911,067 for, 17,877 against, 44,898 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Lloyd Carney
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Lloyd Carney”): 213,533,037 for, 8,478,558 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 110,586,578 for, 3,342,434 against, 44,898 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 22,006,289 | 2,391,065 | 0 | 0 | Mixed |
| Fidelity | 13,026,393 | 19,231 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 148 | 589,685 | 0 | 0 | Against |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Alan Garber
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Alan Garber”): 220,695,587 for, 1,315,689 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,922,032 for, 7,065 against, 44,898 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Reshma Kewalramani
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Reshma Kewalramani”): 221,328,875 for, 695,546 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,923,716 for, 7,030 against, 44,897 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michel Lagarde
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Michel Lagarde”): 221,776,280 for, 234,937 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,923,750 for, 7,029 against, 44,898 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jeffrey Leiden
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeffrey Leiden”): 217,823,643 for, 4,195,522 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,869,379 for, 61,452 against, 44,897 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,207 | 147 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,575 | 25 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Diana McKenzie
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Diana McKenzie”): 218,220,365 for, 3,797,695 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,912,866 for, 17,982 against, 44,898 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Bruce Sachs
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Bruce Sachs”): 207,616,033 for, 14,397,759 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,314,396 for, 616,368 against, 44,898 abstained, 33 not voted, 100 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,499 | 101 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jennifer Schneider
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jennifer Schneider”): 221,774,054 for, 240,910 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,923,785 for, 7,029 against, 44,898 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Nancy Thornberry
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Nancy Thornberry”): 221,772,658 for, 241,378 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,921,949 for, 7,029 against, 44,898 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Suketu Upadhyay
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Suketu Upadhyay”): 221,237,300 for, 770,815 against, per its Form 8-K filed May 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 225 asset managers below reported 113,921,892 for, 7,034 against, 44,898 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Showing the 25 largest of 225 asset managers. All 225 are in the interactive database (link above).
Combines 29 wordings of this item as funds reported it.
91% Approved · of votes cast
Description as filed by funds: Advisory vote to approve named executive office compensation.
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2023 compensation program for the Company's named executive officers:”): 202,098,575 for, 19,223,784 against — passed, per its Form 8-K filed May 15, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 : Based upon the following votes, the shareholders approved, on an advisory basis, the 2023 compensation program for the Company's named executive officers:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,281,457 | 14,199 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 288,288 | 423,930 | 0 | 0 | Mixed |
| American Century | 341,542 | 269,588 | 0 | 0 | Mixed |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,685 | 148 | 0 | 0 | For |
Fund voting reports, all 214 managers: 113,149,075 for, 1,186,810 against, 44,938 abstained, 33 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 19,205,493 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 11,994,183 | 0 | 0 | 0 | For |
| Fidelity | 9,893,219 | 0 | 0 | 0 | For |
| BlackRock | 9,325,101 | 1,073 | 0 | 0 | For |
| State Street | 7,724,394 | 0 | 0 | 0 | For |
| AllianceBernstein | 6,761,308 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,783,458 | 0 | 0 | 0 | For |
| JPMorgan | 5,533,031 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,651,060 | 35,219 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 4,356,436 | 0 | 0 | 0 | For |
| Wellington | 4,189,872 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3,338,796 | 0 | 0 | 0 | For |
| New York Life | 3,000,000 | 0 | 0 | 0 | For |
| Janus Henderson | 2,615,016 | 0 | 0 | 0 | For |
| Northern Trust | 2,493,274 | 18,445 | 0 | 0 | For |
| Clearbridge Investments, LLC | 2,332,555 | 0 | 0 | 0 | For |
| Invesco | 1,873,609 | 0 | 0 | 0 | For |
| Amundi | 0 | 1,744,641 | 0 | 0 | Against |
| UBS | 0 | 1,698,691 | 0 | 0 | Against |
| Charles Schwab | 1,562,559 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 1,546,008 | 0 | 0 | Against |
| Legal & General Investment Management Ltd | 0 | 1,456,953 | 0 | 0 | Against |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 0 | 1,336,211 | 0 | 0 | Against |
| AMUNDI ASSET MANAGEMENT US, INC. | 1,293,014 | 0 | 0 | 0 | For |
| Vanguard | 1,136,767 | 0 | 0 | 0 | For |
Institutional-manager reports, all 960 managers: 140,505,818 for, 14,588,887 against, 179 withheld, 240,436 abstained, 7,631 not voted, 1,676 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2024.
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024:”): 229,460,523 for, 3,987,619 against — passed, per its Form 8-K filed May 15, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 : Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 24,397,354 | 0 | 0 | 0 | For |
| Fidelity | 13,045,624 | 0 | 0 | 0 | For |
| BlackRock | 8,843,048 | 0 | 0 | 0 | For |
| JPMorgan | 4,396,347 | 0 | 0 | 0 | For |
| State Street | 3,012,499 | 101 | 0 | 0 | For |
| T. Rowe Price | 2,295,656 | 0 | 0 | 0 | For |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,728,087 | 0 | 0 | 0 | For |
| Invesco | 1,589,208 | 0 | 0 | 0 | For |
| Charles Schwab | 1,526,342 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,265,327 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,013,516 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 712,218 | 0 | 0 | 0 | For |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
Fund voting reports, all 213 managers: 113,817,358 for, 24,301 against, 47,699 abstained, 33 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RWC Asset Management LLP | 3,931,547 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 76,805 | 0 | 0 | 0 | For |
| Decatur Capital Management, Inc. | 5,192 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 2,789 | 0 | 0 | 0 | For |
| Williamson Legacy Group, LLC | 2,247 | 0 | 0 | 0 | For |
| HOWLAND CAPITAL MANAGEMENT LLC | 973 | 0 | 0 | 0 | For |
| MARCO INVESTMENT MANAGEMENT LLC | 261 | 0 | 0 | 0 | For |
| Warren Street Wealth Advisors, LLC | 205 | 0 | 0 | 0 | For |
| Berkeley Capital Partners, LLC | 171 | 0 | 0 | 0 | For |
| Renaissance Investment Group LLC | 0 | 0 | 0 | 0 | -- |
| ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC | 99 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 90 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 50 | 0 | 0 | 0 | For |
| Evernest Financial Advisors, LLC | 17 | 0 | 0 | 0 | For |
Institutional-manager reports, all 14 managers: 4,020,446 for, 100 unknown.
Combines 8 wordings of this item as funds reported it.
29% Not approved · of votes cast
Description as filed by funds: Shareholder proposal, if properly presented at the meeting, regarding a report on racial and gender pay gaps.
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 5: Based upon the following votes, the shareholders did not approve a shareholder proposal regarding a report on racial and gender pay gaps:”): 63,865,687 for, 157,637,997 against — failed, per its Form 8-K filed May 15, 2024 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “Proposal No. 5: Based upon the following votes, the shareholders did not approve a shareholder proposal regarding a report on racial and gender pay gaps:”
Support: 29% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 232 asset managers below reported 9,537,321 for, 104,089,679 against, 480,900 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 0 | 26,513,674 | 0 | 0 | Against |
| Vanguard | 2,047 | 24,395,307 | 0 | 0 | Against |
| Fidelity | 4,438 | 13,041,186 | 0 | 0 | Against |
| BlackRock | 3,926 | 8,839,122 | 0 | 0 | Against |
| JPMorgan | 8,380 | 4,387,967 | 0 | 0 | Against |
| State Street | 987 | 3,011,613 | 0 | 0 | Against |
| T. Rowe Price | 0 | 2,295,656 | 0 | 0 | Against |
| MFS | 0 | 1,867,336 | 0 | 0 | Against |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,497,107 | 230,980 | 0 | 0 | Mixed |
| Invesco | 0 | 1,589,208 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,526,342 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 0 | 1,455,066 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 1,265,327 | 0 | 0 | Against |
| Columbia Threadneedle | 736,528 | 380,655 | 0 | 0 | Mixed |
| HARBOR FUNDS | 0 | 1,013,516 | 0 | 0 | Against |
| NEW ECONOMY FUND | 0 | 994,250 | 0 | 0 | Against |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 827,167 | 0 | 0 | Against |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 0 | 798,032 | 0 | 0 | Against |
| Jackson National | 11,836 | 700,382 | 0 | 0 | Against |
| American Century | 0 | 611,130 | 0 | 0 | Against |
| PIONEER FUND /MA/ | 0 | 607,746 | 0 | 0 | Against |
| Hartford | 148 | 589,685 | 0 | 0 | Against |
Showing the 25 largest of 232 asset managers. All 232 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
72% Approved · of votes cast
Description as filed by funds: Shareholder proposal, if properly presented at the meeting, regarding special shareholder meeting improvement.
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders approved a shareholder proposal regarding a special shareholder meeting improvement:”): 160,438,357 for, 61,494,550 against — passed, per its Form 8-K filed May 15, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 4: Based upon the following votes, the shareholders approved a shareholder proposal regarding a special shareholder meeting improvement:”
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 217 asset managers below reported 76,599,287 for, 27,888,972 against, 66,619 abstained, 33 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 26,513,674 | 0 | 0 | 0 | For |
| Vanguard | 23,916,906 | 480,447 | 0 | 0 | For |
| Fidelity | 146,727 | 12,898,897 | 0 | 0 | Against |
| JPMorgan | 0 | 4,396,347 | 0 | 0 | Against |
| State Street | 3,012,021 | 579 | 0 | 0 | For |
| T. Rowe Price | 14,199 | 2,281,457 | 0 | 0 | Against |
| MFS | 1,867,336 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 1,759,487 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,497,107 | 230,980 | 0 | 0 | Mixed |
| Invesco | 0 | 1,589,208 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,526,342 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 1,455,066 | 0 | 0 | 0 | For |
| Prudential/PGIM | 173,762 | 1,091,565 | 0 | 0 | Mixed |
| Columbia Threadneedle | 1,117,183 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 0 | 1,013,516 | 0 | 0 | Against |
| NEW ECONOMY FUND | 994,250 | 0 | 0 | 0 | For |
| Legg Mason | 852,587 | 0 | 0 | 0 | For |
| Loomis Sayles | 827,167 | 0 | 0 | 0 | For |
| TIAA | 816,903 | 0 | 0 | 0 | For |
| AMCAP FUND | 798,032 | 0 | 0 | 0 | For |
| Jackson National | 484,422 | 227,796 | 0 | 0 | Mixed |
| American Century | 611,130 | 0 | 0 | 0 | For |
| PIONEER FUND /MA/ | 607,746 | 0 | 0 | 0 | For |
| Hartford | 589,833 | 0 | 0 | 0 | For |
| Victory Capital | 523,753 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. All 217 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of May 14, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 258,296,249 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 10.26% |
| 2 | Vanguard | 9.45% |
| 3 | Fidelity | 5.05% |
| 4 | BlackRock | 3.42% |
| 5 | JPMorgan | 1.70% |
| 6 | State Street | 1.17% |
| 7 | T. Rowe Price | 0.89% |
| 8 | MFS | 0.72% |
| 9 | AB LARGE CAP GROWTH FUND INC | 0.68% |
| 10 | JANUS INVESTMENT FUND | 0.67% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 7.44% |
| 2 | Capital Research Global Investors | 4.64% |
| 3 | Fidelity | 3.83% |
| 4 | BlackRock | 3.61% |
| 5 | State Street | 2.99% |
| 6 | AllianceBernstein | 2.62% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.24% |
| 8 | JPMorgan | 2.14% |
| 9 | T. Rowe Price | 1.81% |
| 10 | JENNISON ASSOCIATES LLC | 1.69% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 24,216,865 | 9.38% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 22,253,047 | 8.62% | Form 13F, quarter ended March 31, 2024 |
| Capital World Investors | 22,080,207 | 8.55% | Proxy statement (DEF 14A), proxy filed April 4, 2024 |
| FMR LLC | 12,981,286 | 5.03% | Proxy statement (DEF 14A), proxy filed April 4, 2024 |
| State Street | 12,006,483 | 4.65% | Form 13F, quarter ended March 31, 2024 |
| JPMorgan Chase | 6,434,778 | 2.49% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 5,813,036 | 2.25% | Form 13F, quarter ended March 31, 2024 |
| Wellington Management | 4,558,233 | 1.76% | Form 13F, quarter ended March 31, 2024 |
| T. Rowe Price | 4,493,422 | 1.74% | Form 13F, quarter ended March 31, 2024 |
| FMR (Fidelity) | 3,303,768 | 1.28% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 258,296,249 shares outstanding, as reported by VERTEX PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At VERTEX PHARMACEUTICALS INC.'s shareholder meeting held May 15, 2024, in the 2023-2024 proxy season, 1,145 asset managers reported votes on at least one of its 15 ballot items in their SEC Form N-PX filings, covering 20,137 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve named executive office compensation. — VERTEX PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VERTEX PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VERTEX PHARMACEUTICALS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
VERTEX PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “VERTEX PHARMACEUTICALS (VRTX) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/vertex-pharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.